Pancreatic Cancer: Promises and Failures of Target Therapies

被引：7
|
作者：
Aroldi, Francesca [1 ]
Bertocchi, Paola [1 ]
Rosso, Edoardo [2 ]
Prochilo, Tiziana [1 ]
Zaniboni, Alberto [1 ]
机构：
[1] Fdn Poliambulanza, UO Oncol Med, Brescia, Italy
[2] Fdn Poliambulanza, Dept Surg, Brescia, Italy
来源：
REVIEWS ON RECENT CLINICAL TRIALS | 2016年 / 11卷 / 01期
关键词：
Angiogenesis; hedgehog-; JAK-STAT; -notch; immunotherapy; pancreatic cancer; stroma; target therapies;
D O I：
10.2174/1574887110666150930122720
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Currently, few efficient therapies are available to battle pancreatic cancer. Mechanisms underlying this cancer are not well known and researchers are trying to identify new therapeutic targets. Here, we present a review of new treatments and their results in recent years.
引用
收藏
页码：33 / 38
页数：6
相关论文
共 50 条
  • [41] Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures
    Locatelli, Marzia
    Curigliano, Giuseppe
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (06) : 411 - 427
  • [42] Cancer: Diabetes therapies affect pancreatic cancer risk
    Allison S.J.
    Nature Reviews Gastroenterology & Hepatology, 2009, 6 (10) : 563 - 563
  • [43] Targeted Therapies in Early-Stage Breast Cancer: Achievements and Promises
    Sledge, George W., Jr.
    Jotwani, Aparna C.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 19 (03) : 669 - +
  • [44] Successes and Failures of Combined Modality Therapies in Head and Neck Cancer
    Bowles, Daniel W.
    Deutsch, Eric
    Raben, David
    SEMINARS IN RADIATION ONCOLOGY, 2016, 26 (04) : 299 - 306
  • [45] Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis therapies to target breast cancer metastasis
    Yang, Yu-an
    Yang, Howard
    Hu, Ying
    Watson, Peter
    Liu, Huaitian
    Geiger, Thomas R.
    Anver, Miriam R.
    Haines, Diana
    Martin, Philip
    Lee, Maxwell P.
    Hunter, Kent W.
    Wakefield, Lalage M.
    CANCER RESEARCH, 2017, 77
  • [46] Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics
    Soo, Ross A.
    Yong, Wei-Peng
    Innocenti, Federico
    CURRENT DRUG TARGETS, 2012, 13 (06) : 811 - 828
  • [47] Multimodal therapies in ductal pancreatic cancer - The future
    Link, KH
    Gansauge, F
    Pillasch, J
    Beger, HG
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1997, 21 (01) : 71 - 83
  • [48] Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies
    Bazeed, Alaa Y.
    Day, Candace M.
    Garg, Sanjay
    CANCERS, 2022, 14 (17)
  • [49] Adjuvant and neoadjuvant therapies of pancreatic cancer - A review
    Harris, J
    Bruckner, H
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 2001, 29 (01) : 1 - 7
  • [50] Novel therapies for pancreatic cancer: setbacks and progress
    Wong, Han Hsi
    Lemoine, Nicholas R.
    FUTURE ONCOLOGY, 2010, 6 (07) : 1061 - 1064
12345